Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 158

Tests names and labsConditionsGenes and analytesMethods

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Tissue of Origin

Cancer Genetics, Inc.
United States
141
  • R RNA analysis

Hereditary Cancer Panel - High Penetrance 16

Molecular Genetics Laboratory London Health Sciences Centre
Canada
2816
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
4030
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
4062
  • C Sequence analysis of the entire coding region

Cancer Hotspot Panel

Centogene AG - the Rare Disease Company
Germany
4688
  • E Sequence analysis of select exons

Myeloid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
3253
  • X Mutation scanning of select exons

Endometrial carcinoma, somatic

Centogene AG - the Rare Disease Company
Germany
11
  • C Sequence analysis of the entire coding region

PIK3CA Mutation by Sequencing

Cancer Genetics, Inc.
United States
61
  • E Sequence analysis of select exons

Endometrial carcinoma

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Lynch Syndrome gene sequencing and deletion/dupliction analysis

Molecular Diagnostics Laboratory University Health Network
Canada
85
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Sequencing Panel with CNV Detection

PreventionGenetics
United States
2221
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Breast and Ovarian Cancer - High Risk and Lynch Syndrome Sequencing Panel with CNV Detection

PreventionGenetics
United States
1917
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Endometrial Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
1712
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Ovarian Cancer Sequencing Panel with CNV Detection

PreventionGenetics
United States
3521
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

myRisk Hereditary Cancer

Myriad Genetic Laboratories, Inc.
United States
1928
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Colon and Endometrial Cancer-ColoNGS

GeneKor MSA
Greece
107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch Syndrome

GeneKor MSA
Greece
75
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Lynch Syndrome: MLH1, MSH2, MSH6, PMS2, and EPCAM Sequencing and Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
44
  • C Sequence analysis of the entire coding region

Lynch Syndrome: MLH, MSH2, MSH6, and EPCAM Sequencing and Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
44
  • S Mutation scanning of the entire coding region

Results: 1 to 20 of 158

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center